Stay updated on Durvalumab with Chemoradiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study record history now includes the latest page revision tag v3.7.0 and removes the previous v3.6.6 tag, reflecting an update to the page's version history. This change represents an update to how the page versions are tracked rather than content changes.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry (v3.6.6) was added to the study record history, and the previous revision (v3.6.5) was removed from the history list, updating the record's version history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe study history now shows a new latest revision (v3.6.5) and removes the previous revision (v3.6.4), updating the record's revision log to reflect the latest changes.SummaryDifference0.1%

- Check83 days agoChange DetectedThe study history shows a new revision entry (v3.6.4) that supersedes the earlier v3.6.3, reflecting an update to the record.SummaryDifference0.1%

- Check90 days agoChange DetectedVersion history shows the study status updated to Completed with a corresponding recruitment status change. This indicates that enrollment has ended and the trial has concluded.SummaryDifference0.4%

Stay in the know with updates to Durvalumab with Chemoradiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page.